GovBidAlerts
← All opportunities
This notice has been superseded. See the latest notice: Quetiapine Fumarate XR Tablets (Award Notice)

Quetiapine Fumarate XR Tablets

Key dates

Posted
Sep 7, 2023
Response deadline
—
Archive date
Oct 17, 2029
Archive type
autocustom

Classification

Notice type
Award Notice
Base type
Solicitation
Set-aside
—
Set-aside code
—
PSC
6505

NAICS

  • 325412Pharmaceutical Preparation Manufacturing

    This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Cross-References. Establishments primarily engaged in--

Issuing office

Department
DEPT OF DEFENSE
Sub-tier
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Office code
—
Organization type
OFFICE
Office address
PHILADELPHIA, PA, 19111, USA

Place of performance

Street
—
Street 2
—
City
Hauppauge
State
NY
Zip
11788
Country
USA

Contacts

Description

Award SPE2D223D0012 Quetiapine Fumarate XR Tablets

Award

Number
SPE2D223D0012
Amount
$4,329,877.25
Date
Sep 7, 2023
Awardee
GOLDEN STATE MEDICAL SUPPLY INC Camarillo CA 93012 USA
UEI
—
Awardee address
—

Other notices in this solicitation

Similar open contracts

Similar past awards

Metadata

Notice ID
f68dae132da145539a004f5e4ee93c99
Full path
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.DLA TROOP SUPPORT
Office code
—
Ingested
May 2, 2026
Updated
May 2, 2026
Raw record
{
  "CGAC": "097",
  "City": "PHILADELPHIA",
  "Link": "https://sam.gov/workspace/contract/opp/f68dae132da145539a004f5e4ee93c99/view",
  "Sol#": "SPE2D223D0012",
  "Type": "Award Notice",
  "State": "PA",
  "Title": "Quetiapine Fumarate XR Tablets",
  "Active": "Yes",
  "Award$": "4329877.25",
  "Office": "DLA TROOP SUPPORT",
  "PopZip": "11788",
  "Awardee": "GOLDEN STATE MEDICAL SUPPLY INC Camarillo CA 93012 USA",
  "PopCity": "Hauppauge",
  "ZipCode": "19111",
  "AAC Code": "SPE2D2",
  "BaseType": "Solicitation",
  "NoticeId": "f68dae132da145539a004f5e4ee93c99",
  "PopState": "NY",
  "SetASide": "",
  "Sub-Tier": "DEFENSE LOGISTICS AGENCY",
  "AwardDate": "2023-09-07",
  "FPDS Code": "97AS",
  "NaicsCode": "325412",
  "PopCountry": "USA",
  "PostedDate": "2023-09-07 14:55:25.948-04",
  "ArchiveDate": "2029-10-17",
  "ArchiveType": "autocustom",
  "AwardNumber": "SPE2D223D0012",
  "CountryCode": "USA",
  "Description": "Award SPE2D223D0012 Quetiapine Fumarate XR Tablets",
  "SetASideCode": "",
  "OrganizationType": "OFFICE",
  "PopStreetAddress": "",
  "ResponseDeadLine": "",
  "PrimaryContactFax": "",
  "AdditionalInfoLink": "",
  "ClassificationCode": "6505",
  "PrimaryContactEmail": "Phyllis.Daraio@dla.mil",
  "PrimaryContactPhone": "2157377941",
  "PrimaryContactTitle": "",
  "SecondaryContactFax": "",
  "Department/Ind.Agency": "DEPT OF DEFENSE",
  "SecondaryContactEmail": "",
  "SecondaryContactPhone": "",
  "SecondaryContactTitle": "",
  "PrimaryContactFullname": "Phyllis Daraio",
  "SecondaryContactFullname": ""
}